Organisms | Evidence |
---|---|
Mus musculus (house mouse) | |
Homo sapiens (human) | |
Rattus norvegicus (Norway rat) | |
Viruses | |
Gallus gallus (chicken) |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
FUT10 | GDP-Fuc |
G39213VZ
|
R |
G64669AQ
|
R | |
FUT11 | GDP-Fuc |
G39213VZ
|
R |
G64669AQ
|
R | |
MGAT3 | UDP-GlcNAc |
G39213VZ
|
Asn-X |
G59471TH
|
Asn-X | |
MGAT4A | UDP-GlcNAc |
G39213VZ
|
PA |
G29011JC
|
PA | |
MGAT5 | UDP-GlcNAc |
G39213VZ
|
Asn-X |
G10219AA
|
Asn-X |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
FUT10 | GDP-Fuc |
G39213VZ
|
R |
G64669AQ
|
R | |
FUT8 | GDP-Fuc |
G39213VZ
|
Free |
G80858MF
|
Free | |
FUT11 | GDP-Fuc |
G39213VZ
|
R |
G64669AQ
|
R | |
MGAT5 | UDP-GlcNAc |
G39213VZ
|
[beta]1-Asn |
G10219AA
|
[beta]1-Asn | |
MGAT3 | UDP-GlcNAc |
G39213VZ
|
Asn-X |
G59471TH
|
Asn-X |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
P02771 | Alpha-fetoprotein | ||
P05540 | T-cell surface glycoprotein CD4 | ||
P07602 | Prosaposin | ||
P08637 | Low affinity immunoglobulin gamma Fc region receptor III-A | ||
P0DTC2 | Spike glycoprotein | ||
P10252 | CD48 antigen | ||
P12314 | High affinity immunoglobulin gamma Fc receptor I | ||
P12318 | Low affinity immunoglobulin gamma Fc region receptor II-a | ||
P13987 | CD59 glycoprotein | ||
P29965 | CD40 ligand |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl 3b:b-dglc-HEX-1:5 4s:n-acetyl 5b:b-dman-HEX-1:5 6b:a-dman-HEX-1:5 7b:b-dglc-HEX-1:5 8s:n-acetyl 9b:a-dman-HEX-1:5 10b:b-dglc-HEX-1:5 11s:n-acetyl LIN 1:1d(2+1)2n 2:1o(4+1)3d 3:3d(2+1)4n 4:3o(4+1)5d 5:5o(3+1)6d 6:6o(2+1)7d 7:7d(2+1)8n 8:5o(6+1)9d 9:9o(2+1)10d 10:10d(2+1)11n
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024